Ochratoxin A and Human Health Risk: A Review of the Evidence

REFERENCES

• Abid, S., Hassen, W., Achour, A., Skhiri, H., Maaroufi, K., Ellouz, F., Creppy, E. and Bacha, H. (2003). Ochratoxin A and chronic human nephropathy in Tunisia: is the situation endemic? Hum. Exp. Toxicol. 22:77–84.
   PubMed Web of Science ®Google Scholar
• Ahn, J., Kim, D., Kim, H. and Jahng, K. Y. (2010). Quantitative determination of mycotoxins in urine by LC-MS/MS. Food Addit. Contam. Part A Chem. Anal. Control. Expo. Risk. Assess. 27:1674–1682.
   PubMed Web of Science ®Google Scholar
• Baker, R. J. and Pusey, C. D. (2004). The changing profile of acute tubulointerstitial nephritis. Nephrol. Dial. Transplant. 19:8–11.
   PubMed Web of Science ®Google Scholar
• Barnes, J. M., Austwick, P. K., Carter, R. L., Flynn, F. V., Peristianis, G. C. and Aldridge, W. N. (1977). Balkan (endemic) nephropathy and a toxin-producing strain of Penicillium verrucosum var cyclopium: An experimental model in rats. Lancet. 1:671–675.
   PubMed Web of Science ®Google Scholar
• Bondy, G. S. and Pestka, J. J. (2000). Immunomodulation by fungal toxins. J. Toxicol. Environ. Health B Crit. Rev. 3:109–143.
   PubMed Web of Science ®Google Scholar
• Breitholtz-Emanuelsson, A., Minervini, F., Hult, K. and Visconti, A. (1994). Ochratoxin A in human serum samples collected in southern Italy from healthy individuals and individuals suffering from different kidney disorders. Natural. Toxins. 2:366–370.
   PubMedGoogle Scholar
• Castegnaro, M., Canadas, D., Vrabcheva, T., Petkova-Bocharova, T., Chernozemsky, I. N. and Pfohl-Leszkowicz, A. (2006). Balkan endemic nephropathy: Role of ochratoxins A through biomarkers. Mol. Nutr. Food. Res. 50:519–529.
   PubMed Web of Science ®Google Scholar
• Castegnaro, M., Maru, V., Maru, G. and Ruiz-Lopez, M. D. (1990). High-performance liquid chromatographic determination of ochratoxin A and its 4R-4-hydroxy metabolite in human urine. Analyst. 115:129–131.
   PubMed Web of Science ®Google Scholar
• Coronel, M. B., Marin, S., Tarrago, M., Cano-Sancho, G., Ramos, A. J. and Sanchis, V. (2011). Ochratoxin A and its metabolite ochratoxin alpha in urine and assessment of the exposure of inhabitants of Lleida, Spain. Food. Chem. Toxicol. 49:1436–1442.
   PubMed Web of Science ®Google Scholar
• Dahlmann, A., Dantzler, W. H., Silbernagl, S. and Gekle, M. (1998). Detailed mapping of ochratoxin A reabsorption along the rat nephron in vivo: the nephrotoxin can be reabsorbed in all nephron segments by different mechanisms. J. Pharmacol. Esp. Ther. 286:157–162.
   PubMed Web of Science ®Google Scholar
• Domijan, A. M., Peraica, M., Markov, K. and Fuchs, R. (2009). Urine ochratoxin A and sphinganine/sphingosine ratio in residents of the endemic nephropathy area in Croatia. Arh. Hig. Rada. Toksikol. 60:387–393.
   PubMed Web of Science ®Google Scholar
• Duarte, S. C., Bento, J. M., Pena, A. and Lino, C. M. (2009). Ochratoxin A exposure assessment of the inhabitants of Lisbon during winter 2007/2008 through bread and urine analysis. Food Addit. Contam. Part A Chem. Anal. Control. Expo. Risk Assess. 26:1411–1420.
   PubMed Web of Science ®Google Scholar
• Duarte, S., Bento, J., Pena, A., Lino, C. M., Delerue-Matos, C., Oliva-Teles, T., Morais, S., Correia, M., Oliveira, M. B., Alves, M. R. and Pereira, J. A. (2010a). Monitoring of ochratoxin A exposure of the Portuguese population through a nationwide urine survey—Winter 2007. Sci. Total. Environ. 408:1195–1198.
   PubMed Web of Science ®Google Scholar
• Duarte, S. C., Pena, A. and Lino, C. M. (2010b). Ochratoxin A in Portugal: a review to assess human exposure. Toxins. (Basel). 2:1225–1249.
   PubMed Web of Science ®Google Scholar
• Duarte, S. C., Pena, A. and Lino, C. M. (2011). Human ochratoxin A biomarkers—From exposure to effect. Cr. Rev. Toxicol. 41:187–212.
   PubMed Web of Science ®Google Scholar
• Elling, F. (1979). Ochratoxin A-induced mycotoxic porcine nephropathy: alterations in enzyme activity in tubular cells. Acta Pathol. Microbiol. Scand. 87:237–243.
   Google Scholar
• Elling, F. and Krogh, P. (1977). Fungal toxins and Balkan (endemic) nephropathy. Lancet. 1:1213.
   PubMed Web of Science ®Google Scholar
• European Food Safety Authority (EFSA). (2006). Opinion of the scientific panel on contaminants in the food chain on a request from the commission related to ochratoxin A in food. The EFSA Journal 365:1–56.
   Google Scholar
• Fazekas, B., Tar, A. and Kovacs, M. (2005). Ochratoxin a content of urine samples of healthy humans in Hungary. Acta Vet. Hung. 53:35–44.
   PubMed Web of Science ®Google Scholar
• Gilbert, J., Brereton, P. and MacDonald, S. (2001). Assessment of dietary exposure to ochratoxin A in the UK using a duplicate diet approach and analysis of urine and plasma samples. Food Addit. Contam. 18:1088–1093.
   PubMed Web of Science ®Google Scholar
• Godin, M., Francois, A., Le Roy, M., Morin, J.-P., Creppy, E., Hemet, J. and Fillastre, J. P. (1996). Karyomegalic interstitial nephritis. Am. J. Kidney Dis. 27:166.
   PubMed Web of Science ®Google Scholar
• Grollman, A. P., Shibutani, S., Moriya, M., Miller, F., Wu, L., Moll, U., Suzuki, N., Fernandes, A., Rosenquist, T., Medverec, Z., Jakovina, K., Brdar, B., Slade, N., Turesky, R. J., Goodenough, A. K., Rieger, R., Vukelic, M. and Jelakovic, B. (2007). Aristolochic acid and the etiology of endemic (Balkan) nephropathy. Proc. Natl. Acad. Sci. U S A. 104:12129–12134.
   PubMed Web of Science ®Google Scholar
• Hagelberg, S., Hult, K. and Fuchs, R. (1989). Toxicokinetics of ochratoxin A in several species and its plasma-binding properties. J. Appl. Toxicol. 9:91–96.
   PubMed Web of Science ®Google Scholar
• Haighton, L. A., Lynch, B. S., Magnuson, B. A. and Nestmann, E. R. (2012). A reassessment of risk associated with dietary intake of ochratoxin A based on a lifetime exposure model. Cr. Rev. Toxicol. 42:147–168.
   PubMed Web of Science ®Google Scholar
• Hassen, W., Abid, S., Achour, A., Creppy, E. and Bacha, H. (2004). Ochratoxin A and beta2-microglobulinuria in healthy individuals and in chronic interstitial nephrppathy patients in the centre of Tunisia: a hot spot of Ochratoxin A exposure. Toxicology. 199:185–193.
   PubMed Web of Science ®Google Scholar
• Health Canada. (2009). Information document on health Canada's proposed maximum limits (standards) for the presence of the mycotoxin Ochratoxin A in foods. Safety, B. o. C. Ed., Ottawa. www.hc-sc.gc.ca/fn-an/consult/limits-max-seuils/myco_consult_ochra-eng.php.
   Google Scholar
• IARC (1993). IARC Monographs on the Evaluation of Carcinogenic Risks to Humans: Some Naturally. pp. 489–521. Taylor & Francis, Lyon.
   Google Scholar
• Jimenez, A. M., Lopez de Cerain, A., Gonzalez-Penas, E., Bello, J., Betebeder, A. M. and Creppy, E. E. (1998). Exposure to ochratoxin A in Europe: comparison with a region of northern Spain. J. Toxicol.-Toxin Rev. 17:479–491.
   Web of Science ®Google Scholar
• Joint FAO/WHO Committee On Food Additives (JECFA). (1991). Evaluation of certain food additives and contaminants (Thirty-seventh report) In: WHO Technical Report Series. World Health Organization, Geneva, Switzerland.
   Google Scholar
• Joint FAO/WHO Committee On Food Additives (JECFA). (2001). Safety Evaluations of Certain Mycotoxins in Food. In: JECFA Food Additives Series. Food and Agriculture Organization, Rome, Italy.
   Google Scholar
• Joint FAO/WHO Committee On Food Additives (JECFA). (2007). Evaluation of certain food additives and contaminants (Sixty-eighth report) of the Joint FAO/WHO Expert Committee on Food Additives). In: WHO Technical Report Series. World Health Organization, Geneva, Switzerland.
   Google Scholar
• Jonsyn-Ellis, F. E. (2001). Seasonal variation in exposure frequency and concentration levels of aflatoxins and ochratoxins in urine samples of boys and girls. Mycopathologia. 152:35–40.
   PubMed Web of Science ®Google Scholar
• Jørgensen, K., Rasmussen, G., and Thorup, I. (1996). Ochratoxin A in Danish cereals 1986–1992. Food Addit. Contam. 13:95–104.
   PubMedGoogle Scholar
• Kawamura, O., Maki, S., Sato, S., and Ueno, Y. (1993). Ochratoxin A in livestock and human sera in Japan quantified by a sensitive ELISA. In: Human ochratoxicosis and its pathologies, pp. 123–127. Creppy E. E., Castegnaro M. and Dirheimer G., Eds. Montrouge, France: John Libbey Eurotext.
   Google Scholar
• Khalef, A., Zidane, C., Charef, A., Gharbi, A., Tadjerouna, M., Betbeder, A. M. and Creppy, E. E. (1993). Ochratoxicose humaine en Algerie. In: Human Ochratoxicosis and its Pathologies, pp. 167–174. Creppy E. E., Castegnaro M., Dirheimer G., Eds, Montrouge, France: John Libbey Eurotext.
   Google Scholar
• Krogh, P. (1974). Mycotoxic porcine neprophathy: A possible model for Balkan endemic nephropathy. In: Endemic Nephropathy, Sofia, Bulgaria. Publishing House of the Bulgarian Academy of Science, pp. 266–270. Puhlev, A., Ed.
   Google Scholar
• Kuiper-Goodman, T. (2004). Risk assessment and risk management of mycotoxins in food. In: Mycotoxins in Food. Detection and Control, pp. 3–31. Magan N., Olsen M., Eds., Taylor & Francis, Boca Raton, FL.
   Google Scholar
• Kuiper-Goodman, T., Hilts, C., Billiard, S. M., Kiparissis, Y., Richard, I. K. and Hayward, S. (2010). Health risk assessment of ochratoxin A for all age-sex strata in a market economy. Food Addit. Contam. 27:212–240.
   PubMed Web of Science ®Google Scholar
• Kuiper-Goodman, T. and Scott, P. M. (1989). Risk assessment of the mycotoxin ochratoxin A. Biomed. Environ. Sci. 2:179–248.
   PubMedGoogle Scholar
• Liu, Y., Chang, C. C., Marsh, G. M. and Wu, F. (2012). Population attributable risk of aflatoxin-related liver cancer: Systematic review and meta-analysis. Eur. J. Cancer. 48:2125 –2136.
   Web of Science ®Google Scholar
• Liu, Y. and Wu, F. (2010). Global burden of aflatoxin-induced hepatocellular carcinoma: a risk assessment. Env Health Perspec. 118: 818–824.
   PubMed Web of Science ®Google Scholar
• Maaroufi, K., Achour, A., Betbeder, A. M., Hammami, M., Ellouz, F., Creppy, E. E. and Bacha, H. (1995). Foodstuffs and human blood contamination by the mycotoxin ochratoxin A: correlation with chronic interstitial nephropathy in Tunisia. Arch. Toxicol. 69:552–558.
   PubMed Web of Science ®Google Scholar
• Malir, F., Brndiar, M., Roubal, T., Severa, J., Fixa, P., Kacerovsky, J., Zahradnik, J., Osterreicher, J., Knizek, H. and Cerna, M. (2001a). A study of the accumulation of ochratoxin A (OTA) in patients with chronic renal insufficiency (CHRI) in the Czech Republic. Mycotoxin Res. 17:39–44.
   PubMedGoogle Scholar
• Malir, F., Roubal, T., Brndiar, M., Osterreicher, J., Severa, J., Knizek, H., Kacerovsky, J., Tmejova, M., Bebeder, A. M., Baudrimont, I. and Creppy, E. E. (2001b). Ochratoxin A in the Czech Republic. J. Toxicol.-Toxin Rev. 20:261–274.
   Web of Science ®Google Scholar
• Manique, R., Pena, A., Lino, C. M., Molto, J. C. and Manes, J. (2008). Ochratoxin A in the morning and afternoon portions of urine from Coimbra and Valencian populations. Toxicon. 51:1281–1287.
   PubMed Web of Science ®Google Scholar
• Marquardt, R. R. and Frohlich, A. A. (1992). A review of recent advances in understanding ochratoxicosis. J. Anim. Sci. 70:3968–3988.
   PubMed Web of Science ®Google Scholar
• Martlbauer, E., Usleber, E. and Straka, M. (1996). Ochratoxin A im Serum eines Lehrstuhlkollektivs: 1990–1995. In: Mycotoxin Workshop, pp. 97–101. Kulmbach, Germany. Society for Mycotoxin Research.
   Google Scholar
• Moss, M. O. (1996). Mode of formation of ochratoxin A. Food Addit. Contam. 13 Suppl: 5–9.
   PubMedGoogle Scholar
• Munoz, K., Blaszkewicz, M. and Degen, G. H. (2010). Simultaneous analysis of ochratoxin A and its major metabolite ochratoxin alpha in plasma and urine for an advanced biomonitoring of the mycotoxin. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 878:2623–2629.
   PubMed Web of Science ®Google Scholar
• National Research Council (NRC). (1983). Risk assessment in the Federal Government: managing the process. Council, N. R., Ed., Taylor & Francis, Washington, DC.
   Google Scholar
• National Toxicology Program (NTP). (1989). Toxicology and carcinogenesis studies of ochratoxin A (CAS No. 303-47-9) in F344/N rats (gavage studies). Services., D. o. H. a. H. Ed., Research Triangle Park (NC). National Institute of Environmental Health Sciences.
   Google Scholar
• Nikolov, I. G., Chernozemsky, I. N., Petkova-Bocharova, T., Vrabcheva, T., Stojchev, I., Bankov, B., Castegnaro, M., Pfohl-Leszkowicz, A., Dragacci, S., Day, N., Gill, C., Useleber, E., Dietrich, R. and Martlbauer, E. (2002). Review of the cooperative studies of the national oncological centre in Bulgaria on Balkan endemic nephropathy and associated urinary tract tumors. Med. Biol.. 9:119–122.
   Google Scholar
• O’Brien, E. and Dietrich, D. R. (2005). Ochratoxin A: the continuing enigma. Crit. Rev. Toxicol. 35:33–60.
   PubMed Web of Science ®Google Scholar
• Olsen, M., Thorup, I., Knudsen, I., Larsen, J. J., Hald, B. and Olsen, J. (1991). Health Evaluation of Ochratoxin A in Food Products. Taylor & Francis, Copenhagen.
   Google Scholar
• Ozcelik, N., Kosar, A. and Sosal, D. (2001). Ochratoxin A in human serum samples collected in Isparta-Turkey from healthy individuals and individuals suffering from different urinary disorders. Toxicol. Lett. 121:9–13.
   PubMed Web of Science ®Google Scholar
• Palli, D., Miraglia, M., Saieva, C., Masala, G., Cava, E., Colatosti, M., Corsi, A. M., Russo, A. and Brera, C. (1999). Serum levels of ochratoxin A in healthy adults in Tuscany: Correlation with individual characteristics and between repeat measurements. Cancer Epidemiol. Biomar. Prevent. 8:265–269.
   PubMed Web of Science ®Google Scholar
• Pascale, M. and Visconti, A. (2000). Rapid method for the determination of ochratoxin A in urine by immunoaffinity column clean-up and high performance liquid chromatography. Mycopathologia. 152:91–95.
   Web of Science ®Google Scholar
• Pena, A., Seifrtova, M., Lino, C., Silveira, I. and Solich, P. (2006). Estimation of ochratoxin A in Portuguese population: new data on the occurrence in human urine by high performance liquid chromatography with fluorescence detection. Food Chem. Toxicol. 44:1449–1454.
   PubMed Web of Science ®Google Scholar
• Pestka, J. J. and Bondy, G. S. (1994). Mycotoxin-induced immunomodulation In: Immunotoxicology and immunopharmacology, pp. 163–182. Dean, J. H., Luster, M. I., Munson, A. E. and Kimber, I., Eds., Taylor & Francis, New York.
   Google Scholar
• Petkova-Bocharova, T., Castegnaro, M., Pfohl-Leskowicz, A., Garren, L., Grosso, F., Nikolov, I., Vrabcheva, T., Dragacci, S. and Chernozemsky, I. N. (2003). Analysis of ochratoxin A in serum and urine of inhabitants from an area with Balkan endemic nephropathy: a one-month follow-up study. J. Agric. Food. Chem. 52:2404–2410.
   Web of Science ®Google Scholar
• Pfohl-Leszkowicz, A., Petkova-Bocharova, T., Chernozemsky, I. N. and Castegnaro, M. (2002). Balkan endemic nephropathy and associated urinary tract tumours: a review on aetiological causes and the potential role of mycotoxins. Food Addit. Contam. 19:282–302.
   PubMed Web of Science ®Google Scholar
• Radic, B., Fuchs, R., Peraica, M. and Lucic, A. (1997). Ochratoxin A in human sera in the area with endemic nephropathy in Croatia. Toxicol. Lett. 91:105–109.
   PubMed Web of Science ®Google Scholar
• Roth, A., Chakor, K., Creppy, E. E., Kane, A., Roschenthaler, R. and Dirheimer, G. (1988). Evidence for an enterohepatic circulation of ochratoxin A in mice. Toxicol. 48:293–308.
   PubMed Web of Science ®Google Scholar
• Rubert, J., Soriano, J. M., Manes, J. and Soler, C. (2011). Rapid mycotoxin analysis in human urine: a pilot study. Food Chem. Toxicol. 49:2299–2304.
   PubMed Web of Science ®Google Scholar
• Ruprich, J. and Ostry, V. (1993). Health risk assessment of the mycotoxin ochratoxin A to humans: Czech Republic—Brno—1991/92. Cent. Eur. J. Public Health. 1:86–93.
   PubMedGoogle Scholar
• Sattler, T. A., Dimitrov, T. and Hall, P. W. (1977). Relation between endemic (Balkan) nephropathy and urinary-tract tumours. Lancet. 1:278–280.
   PubMed Web of Science ®Google Scholar
• Scott, P. M. (2005). Biomarkers of human exposure to ochratoxin A. Food Addit. Contam. 22 Suppl 1:99–107.
   PubMedGoogle Scholar
• Solfrizzo, M., Gambacorta, L., Lattanzio, V. M., Powers, S. and Visconti, A. (2011). Simultaneous LC-MS/MS determination of aflatoxin M1, ochratoxin A, deoxynivalenol, de-epoxydeoxynivalenol, alpha and beta-zearalenols and fumonisin B1 in urine as a multi-biomarker method to assess exposure to mycotoxins. Anal. Bioanal. Chem. 401:2831–2841.
   PubMed Web of Science ®Google Scholar
• Studer-Rohr, I., Schlatter, J. and Dietrich, D. R. (2000). Kinetic parameters and intraindividual fluctuations of ochratoxin A plasma levels in humans. Arch. Toxicol. 74:499–510.
   PubMed Web of Science ®Google Scholar
• Voo, S., Drugarin, D., Biriescu, A., Margineanu, F., Olariu, R. T. and Koreck, I. A. (2002). Ochratoxin A serum levels in patients with Balkan nephropathy. Cent. Euro. J. Occup. Environ. Med. 8:178–182.
   Google Scholar
• Wafa, E. W., Yahya, R. S., Sobh, M. A., Eraky, I., El-Baz, M., El-Gayar, H. A., Betbeder, A. M. and Creppy, E. E. (1998). Human ochratoxicosis and nephropathy in Egypt: a preliminary study. Hum. Exp. Toxicology. 17:124–129.
   PubMed Web of Science ®Google Scholar
• World Health Organization (WHO). (2002). Evaluation of certain mycotoxins in food. Fifty-sixth report of the Joint FAO/WHO Expert Committee on Food Additives, pp. 27–35. Taylor & Francis, Geneva.
   Google Scholar